Please login to the form below

Not currently logged in
Email:
Password:

ABPI

This page shows the latest ABPI news and features for those working in and with pharma, biotech and healthcare.

NICE launches consultation on its methods of drug evaluation

NICE launches consultation on its methods of drug evaluation

In response to the consultation announcement, the Association of the British Pharmaceutical Industry (ABPI) welcomed NICE’s plans to evaluate the methods it uses to develop its guidance on health technologies. ... executive of the ABPI.

Latest news

More from news
Approximately 96 fully matching, plus 505 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 8 fully matching, plus 49 partially matching documents found.

Latest appointments

  • Roudie Shafie joins OVID Health’s senior team as director Roudie Shafie joins OVID Health’s senior team as director

    Shafie's previous experience includes roles at the ABPI and Pfizer UK. ... Shafie’s career experience includes time spent as head of government affairs at the ABPI and corporate public affairs lead for Pfizer UK.

  • Neurocentrx appoints two members to the board Neurocentrx appoints two members to the board

    His career history has seen him work in private equity and venture capital and he has been president of the ABPI.

  • Professor Carole Longson moves from NICE to the ABPI Professor Carole Longson moves from NICE to the ABPI

    Longson brings research, academic and pharmaceutical industry experience to the ABPI, including seven years as a research lead at GlaxoSmithKline. ... experience, expertise and network in both industry and academia will enable the ABPI to work with our

  • HCA appoints Mike Dixon as its new CEO HCA appoints Mike Dixon as its new CEO

    Commenting on behalf of the HCA Executive Committee, ABPI executive director of communications Aileen Thompson said: “We are really pleased that Mike has decided to lead the HCA at this critical

  • AZ's Lisa Anson elected president of ABPI AZ's Lisa Anson elected president of ABPI

    year. Anson joined the ABPI board in 2012 and has since overseen a number of schemes for the association, including the implementation of the Pharmaceutical Pricing Regulation Scheme. ... Speaking on behalf of the board and all staff at the ABPI, we very

More from appointments
Approximately 21 fully matching, plus 13 partially matching documents found.

Latest from PMHub

  • Our latest additions Our latest additions

    He has also advised the ABPI on its public affairs strategy and has a strong understanding of healthcare systems, having worked with the Royal College of General Practitioners, a range of

  • What can't we afford to treat anymore?

    Chief Executive of the ABPI.

  • Oxford University Press Oxford University Press

    Group Product Manager. Lundbeck Australia. “Since the 2011 update to the ABPI Code of Practice,  our experience is that the authoritative medical books from OUP are proving popular. A mailing we

  • A patient view on the ABPI’s patient collaboration sourcebook A patient view on the ABPI’s patient collaboration sourcebook

    Last month, the ABPI released a much-in-demand document: The Working with Patients and Patient Organisations sourcebook. ... Last month, the ABPI released a much-in-demand document: T he Working with Patients and Patient Organisations sourcebook.

  • Making a Difference - The Future of Pharma

    On a global scale, pharma is one of the least-trusted industries. And this is despite the fact that pharma contributes more than £30 BN each year to the UK economy, supports almost 500, 000 jobs in the UK alone, and donated 1.4 BN treatments to the

More from PMHub
Approximately 3 fully matching, plus 20 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics